Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.21B | $7.40B | $7.53B | $7.73B | $9.44B | $10.8B | $9.88B | $9.25B | $9.87B | $11.0B |
| Revenue growth | — | 2.6% | 1.7% | 2.6% | 22.1% | 14.3% | -8.4% | -6.4% | 6.7% | 11.8% |
| Gross profit | $2.90B | $2.68B | $2.60B | $2.69B | $3.63B | — | — | — | — | — |
| Gross margin | 40.2% | 36.2% | 34.6% | 34.8% | 38.5% | — | — | — | — | — |
| Operating income | $1.28B | $1.17B | $1.10B | $1.23B | $1.97B | $2.38B | $1.43B | $1.26B | $1.35B | $1.56B |
| Operating margin | 17.7% | 15.7% | 14.6% | 15.9% | 20.9% | 22.1% | 14.4% | 13.6% | 13.6% | 14.1% |
| Net income | $645M | $772M | $736M | $858M | $1.43B | $2.00B | $946M | $854M | $871M | $992M |
| Net margin | 8.9% | 10.4% | 9.8% | 11.1% | 15.2% | 18.5% | 9.6% | 9.2% | 8.8% | 9.0% |
| EPS (diluted) | $4.51 | $5.50 | $5.29 | $6.28 | $10.47 | $15.55 | $7.97 | $7.49 | $7.69 | $8.75 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.12B | $1.18B | $1.20B | $1.24B | $2.00B | $2.23B | $1.72B | $1.27B | $1.33B | $1.89B |
| Capital expenditures | $293M | $252M | $383M | $400M | $418M | $403M | $404M | $408M | $425M | $527M |
| Free cash flow | $823M | $923M | $817M | $843M | $1.59B | $1.83B | $1.31B | $864M | $909M | $1.36B |
| Share buybacks | $590M | $465M | $322M | $353M | $325M | $2.20B | $1.41B | $275M | $151M | $450M |
| Dividends paid | $223M | $247M | $266M | $286M | $297M | $309M | $305M | $314M | $331M | $353M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $359M | $137M | $135M | $1.19B | $1.16B | $872M | $315M | $686M | $549M | $420M |
| Total assets | $10.1B | $10.5B | $11.0B | $12.8B | $14.0B | $13.6B | $12.8B | $14.0B | $16.2B | $16.2B |
| Long-term debt | $3.73B | $3.75B | $3.43B | $3.97B | $4.01B | $4.01B | $3.98B | $4.41B | $5.62B | $5.17B |
| Shareholders' equity | $4.63B | $4.92B | $5.22B | $5.64B | $6.76B | $6.44B | $5.89B | $6.31B | $6.78B | $7.17B |
| Retained earnings | $6.61B | $7.14B | $7.60B | $8.17B | $9.30B | $7.65B | $8.29B | $8.82B | $9.36B | $9.99B |
| Shares (wtd avg diluted) | 142M | 140M | 139M | 136M | 136M | 128M | 118M | 113M | 113M | 113M |
Every figure is extracted from QUEST DIAGNOSTICS INC’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.